Metastatic non-clear cell renal cell carcinoma: current therapeutic options
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2008.07462.x/fullpdf
Reference25 articles.
1. Treatment targeted at vascular endothelial growth factor: a promising approach to managing metastatic kidney cancer
2. Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non–Clear-Cell Histology
3. Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes;Abdominal Radiology;2020-09-15
2. On the Application of Flexible Designs When Searching for the Better of Two Anticancer Treatments;Statistical Modeling for Biological Systems;2020
3. Multidetector CT imaging features of invasive renal parenchyma urothelial carcinoma;The British Journal of Radiology;2016-07
4. Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract;Magnetic Resonance Imaging Clinics of North America;2016-02
5. Review of renal cell carcinoma and its common subtypes in radiology;World Journal of Radiology;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3